期刊文献+

盐酸贝那普利联合硝苯地平控释片不同给药时间的降压疗效观察 被引量:2

Observation of depressurization efficacy of benazipril hydrochloride combined with nifedipine controlled release tablets administered at different time
下载PDF
导出
摘要 目的探讨盐酸贝那普利联合硝苯地平控释片不同给药时间的降压疗效。方法选取2011年3月~2013年3月我院进行治疗的高血压患者115例,按照随机数字分为A、B、C三组。结果三组加服比索洛尔5mg的比率比较,差异不显著(P〉0.05)。各组的24hSBP、24hDBP、24hMABP、dSBP、dDBP、dMABP、nSBP、nDBP、nMABP与治疗前血压比较,均显著下降,差异显著(P〈0.05)。三组血压下降值比较,A组与c组间nSBP、nDBP、nMABP比较差异显著(P〈0.05);B组与C组间nDBP、nDBP、nMABP比较差异显著(P〈0.05)。平滑指数比较,A组与c组nSBP、nDBP、nMABP差异显著(P〈0.05),B组与C组nSBP、nDBP、nMABP比较差异显著(P〈0.05)。结论依那普利与硝苯地平联合用药能更好地控制老年患者的血压,降压效果十分优越,具有极高的临床应用价值。 Objective To investigate the depressurization efficacy of benazepril hydrochloride combined with nifedipine controlled release tablets administered at different time. Methods 115 patients with hypertension treated in our hospital from March 2011 to March 2013 were selected and divided into group A, group B and group C according to the random number. Results The three groups were not significantly different in the ratio of additional administration of visoprolol 5mg, with no significant difference(P 〈 0.05). The 24hSBP, 24hDBP, 24hMABP, dSBP, dDBP, dMABP, nSBP, nDBP and nMABP of each group after treatment reduced significantly compared to those before treatment, with significant differences(P 〈 0.05). In terms of the drop-out value of blood pressure, group A and group C were significantly different in nSBP, nDBP and nMABP(P 〈 0.05); group B and group C were significantly different in nDBP, nDBP and nMABP(P 〈 0.05). In terms of smoothness index, group A and group C were significantly different in nSBP, nDBP and nMABP(P 〈 0.05); group B and group C were significantly different in nSBP, nDBP and nMABP(P 〈 0.05). Conclusion Benazepril hydroehloride combined with nifedipine controlled release tablets can better control the elder patients' blood pressure, has excellent depressurization effect and is of quite high clinical application value.
作者 田宇光
出处 《中国医药科学》 2014年第6期24-26,共3页 China Medicine And Pharmacy
关键词 盐酸贝那普利 硝苯地平控释片 不同给药时间 降压疗效 Benazepril hydrochloride Nifedipine controlled release tablets Different administration time Depressurization efficacy
  • 相关文献

参考文献11

二级参考文献53

  • 1中国高血压防治指南修订委员会.中国高血压防治指南标准(2005年修订版)[J].Chin J Hyertens,2005,13(1):1-53.
  • 2卫生部心血管病防治研究中心.中国心血管病报告2006.北京:中国大百科全书出版社,2007.
  • 3Liu L, Zhang Y, Liu G, et al. FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long- term placebo-controlled trial in Chinese hypertensive patients. J Hypertens, 2005,23 : 2157-2572.
  • 4Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004,363:2022-2031.
  • 5Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet ,2003,361 : 1149-1158.
  • 6Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press ,2007,16 : 13-19.
  • 7Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers : a quantitative overview. Hypertension, 2007,50 : 181 - 188.
  • 8Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin Ⅱ Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res,2008,31:657-664.
  • 9Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase Ⅲ, 12-week, muhicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed- dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage Ⅱ hypertension. Clin Ther, 2007,29 : 2667 -2676.
  • 10Chrysant SG. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension : focus on amlodipine/olmesartan combination. Drugs Today (Barc) ,2008,44:443-453.

共引文献1953

同被引文献28

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部